{"id":"https://openalex.org/W2911676331","doi":"https://doi.org/10.3310/hta23030","title":"Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCT","display_name":"Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCT","publication_year":2019,"publication_date":"2019-01-01","ids":{"openalex":"https://openalex.org/W2911676331","doi":"https://doi.org/10.3310/hta23030","mag":"2911676331","pmid":"https://pubmed.ncbi.nlm.nih.gov/30702059","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6378535"},"language":"en","primary_location":{"id":"doi:10.3310/hta23030","doi":"https://doi.org/10.3310/hta23030","is_oa":true,"landing_page_url":"https://doi.org/10.3310/hta23030","pdf_url":"https://njl-admin.nihr.ac.uk/document/download/2021947","source":{"id":"https://openalex.org/S191206091","display_name":"Health Technology Assessment","issn_l":"1366-5278","issn":["1366-5278","2046-4924","2046-4932"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311817","host_organization_name":"NIHR Journals Library","host_organization_lineage":["https://openalex.org/P4310311817"],"host_organization_lineage_names":["NIHR Journals Library"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Technology Assessment","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://njl-admin.nihr.ac.uk/document/download/2021947","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060812676","display_name":"John Strang","orcid":"https://orcid.org/0000-0002-5413-2725","observed_orcids":["https://orcid.org/0000-0002-5413-2725"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"John Strang","raw_affiliation_strings":["National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"],"raw_orcid":"https://orcid.org/0000-0002-5413-2725","affiliations":[{"raw_affiliation_string":"National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077203130","display_name":"Michael Kelleher","orcid":"https://orcid.org/0000-0003-4637-3454","observed_orcids":["https://orcid.org/0000-0003-4637-3454"]},"institutions":[{"id":"https://openalex.org/I200323923","display_name":"South London and Maudsley NHS Foundation Trust","ror":"https://ror.org/015803449","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200323923"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael Kelleher","raw_affiliation_strings":["South London and Maudsley NHS Foundation Trust, Lambeth Addictions Consortium, London, UK"],"raw_orcid":"https://orcid.org/0000-0003-4637-3454","affiliations":[{"raw_affiliation_string":"South London and Maudsley NHS Foundation Trust, Lambeth Addictions Consortium, London, UK","institution_ids":["https://openalex.org/I200323923"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020275537","display_name":"Soraya Mayet","orcid":"https://orcid.org/0000-0002-5701-9568","observed_orcids":["https://orcid.org/0000-0002-5701-9568"]},"institutions":[{"id":"https://openalex.org/I4210102025","display_name":"Humber Teaching NHS Foundation Trust","ror":"https://ror.org/016bnqk64","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210102025"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Soraya Mayet","raw_affiliation_strings":["Specialist Care Group (Addictions), Humber NHS Foundation Trust, Wolverhampton, UK"],"raw_orcid":"https://orcid.org/0000-0002-5701-9568","affiliations":[{"raw_affiliation_string":"Specialist Care Group (Addictions), Humber NHS Foundation Trust, Wolverhampton, UK","institution_ids":["https://openalex.org/I4210102025"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024073544","display_name":"Ed Day","orcid":"https://orcid.org/0000-0002-7106-7013","observed_orcids":["https://orcid.org/0000-0002-7106-7013"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ed Day","raw_affiliation_strings":["National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"],"raw_orcid":"https://orcid.org/0000-0002-7106-7013","affiliations":[{"raw_affiliation_string":"National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082108466","display_name":"Jennifer M. Hellier","orcid":"https://orcid.org/0000-0003-1760-3708","observed_orcids":["https://orcid.org/0000-0003-1760-3708"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jennifer Hellier","raw_affiliation_strings":["Biostatistics and Health Informatics Department, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK","Biostatistics and Health Informatics Department, Institute of Psychiatry,","Psychology & Neuroscience, King's College London, London, UK"],"raw_orcid":"https://orcid.org/0000-0003-1760-3708","affiliations":[{"raw_affiliation_string":"Biostatistics and Health Informatics Department, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"Biostatistics and Health Informatics Department, Institute of Psychiatry,","institution_ids":[]},{"raw_affiliation_string":"Psychology & Neuroscience, King's College London, London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064133586","display_name":"Sarah Byford","orcid":"https://orcid.org/0000-0001-7084-1495","observed_orcids":["https://orcid.org/0000-0001-7084-1495"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sarah Byford","raw_affiliation_strings":["King\u2019s Health Economics, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"],"raw_orcid":"https://orcid.org/0000-0001-7084-1495","affiliations":[{"raw_affiliation_string":"King\u2019s Health Economics, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063912274","display_name":"Caroline Murphy","orcid":"https://orcid.org/0000-0001-7547-8998","observed_orcids":["https://orcid.org/0000-0001-7547-8998"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Caroline Murphy","raw_affiliation_strings":["King\u2019s Clinical Trials Unit, King\u2019s College London, London, UK"],"raw_orcid":"https://orcid.org/0000-0001-7547-8998","affiliations":[{"raw_affiliation_string":"King\u2019s Clinical Trials Unit, King\u2019s College London, London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015176816","display_name":"Blair Kp McLennan","orcid":"https://orcid.org/0000-0002-9411-8100","observed_orcids":["https://orcid.org/0000-0002-9411-8100"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Blair McLennan","raw_affiliation_strings":["King\u2019s Clinical Trials Unit, King\u2019s College London, London, UK"],"raw_orcid":"https://orcid.org/0000-0002-9411-8100","affiliations":[{"raw_affiliation_string":"King\u2019s Clinical Trials Unit, King\u2019s College London, London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085218809","display_name":"James Shearer","orcid":"https://orcid.org/0000-0002-1658-9767","observed_orcids":["https://orcid.org/0000-0002-1658-9767"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"James Shearer","raw_affiliation_strings":["King\u2019s Health Economics, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"],"raw_orcid":"https://orcid.org/0000-0002-1658-9767","affiliations":[{"raw_affiliation_string":"King\u2019s Health Economics, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008416983","display_name":"Elizabeth Ryan","orcid":"https://orcid.org/0000-0001-9367-4204","observed_orcids":["https://orcid.org/0000-0001-9367-4204","https://orcid.org/0000-0002-6802-4194"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elizabeth Ryan","raw_affiliation_strings":["Biostatistics and Health Informatics Department, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK","Biostatistics and Health Informatics Department, Institute of Psychiatry,","Psychology & Neuroscience, King's College London, London, UK"],"raw_orcid":"https://orcid.org/0000-0001-9367-4204","affiliations":[{"raw_affiliation_string":"Biostatistics and Health Informatics Department, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"Biostatistics and Health Informatics Department, Institute of Psychiatry,","institution_ids":[]},{"raw_affiliation_string":"Psychology & Neuroscience, King's College London, London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030252017","display_name":"John Marsden","orcid":"https://orcid.org/0000-0002-1307-2498","observed_orcids":["https://orcid.org/0000-0002-1307-2498"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John Marsden","raw_affiliation_strings":["National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"],"raw_orcid":"https://orcid.org/0000-0002-1307-2498","affiliations":[{"raw_affiliation_string":"National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK","institution_ids":["https://openalex.org/I183935753"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5060812676"],"corresponding_institution_ids":["https://openalex.org/I183935753"],"apc_list":null,"apc_paid":null,"fwci":0.907,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.74277841,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"23","issue":"3","first_page":"1","last_page":"72"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.8920000195503235},{"id":"https://openalex.org/keywords/extended-release-naltrexone","display_name":"extended-release naltrexone","score":0.9380000233650208},{"id":"https://openalex.org/keywords/oral-naltrexone","display_name":"oral naltrexone","score":0.9890000224113464},{"id":"https://openalex.org/keywords/heroin-dependence","display_name":"heroin addiction","score":0.7369999885559082},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.8830000162124634},{"id":"https://openalex.org/keywords/urine-drug-testing","display_name":"urine drug testing","score":0.5809999704360962},{"id":"https://openalex.org/keywords/abstinence","display_name":"abstinence","score":0.5799999833106995},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.7379999756813049},{"id":"https://openalex.org/keywords/addiction-treatment-services","display_name":"addiction services","score":0.5220000147819519}],"concepts":[{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.961866021156311},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8116863965988159},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6886841654777527},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.6861482858657837},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5163887143135071},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.5095303654670715},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.4217885732650757},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30971020460128784},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006113","descriptor_name":"United Kingdom","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008137","descriptor_name":"Longitudinal Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.3310/hta23030","doi":"https://doi.org/10.3310/hta23030","is_oa":true,"landing_page_url":"https://doi.org/10.3310/hta23030","pdf_url":"https://njl-admin.nihr.ac.uk/document/download/2021947","source":{"id":"https://openalex.org/S191206091","display_name":"Health Technology Assessment","issn_l":"1366-5278","issn":["1366-5278","2046-4924","2046-4932"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311817","host_organization_name":"NIHR Journals Library","host_organization_lineage":["https://openalex.org/P4310311817"],"host_organization_lineage_names":["NIHR Journals Library"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Technology Assessment","raw_type":"journal-article"},{"id":"pmid:30702059","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30702059","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health technology assessment (Winchester, England)","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6378535","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6378535/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Technol Assess","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:c7436de429b64220a79e2141161e35ae","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/c7436de429b64220a79e2141161e35ae","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Health Technology Assessment, Vol 23, Iss 3 (2019)","raw_type":"article"},{"id":"pmh:oai:kclpure.kcl.ac.uk:publications/79fb367c-df8c-4eb4-877a-110a72096f1f","doi":null,"is_oa":false,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/79fb367c-df8c-4eb4-877a-110a72096f1f","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Strang, J, Kelleher, M, Mayet, S, Day, E, Hellier, J, Byford, S, Murphy, C, McLennan, B, Shearer, J, Ryan, E & Marsden, J 2019, 'Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder : the NEAT three-arm RCT', Health technology assessment (Winchester, England), vol. 23, no. 3, pp. 1-74. https://doi.org/10.3310/hta23030","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/7cbd8719-a902-47e5-b4fe-a80cc278cf1b","doi":null,"is_oa":true,"landing_page_url":"https://research.birmingham.ac.uk/en/publications/7cbd8719-a902-47e5-b4fe-a80cc278cf1b","pdf_url":null,"source":{"id":"https://openalex.org/S4306402634","display_name":"University of Birmingham Research Portal (University of Birmingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79619799","host_organization_name":"University of Birmingham","host_organization_lineage":["https://openalex.org/I79619799"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Strang, J, Kelleher, M, Mayet, S, Day, E, Hellier, J, Byford, S, Murphy, C, McLennan, B, Shearer, J, Ryan, E & Marsden, J 2019, 'Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCT', Health Technology Assessment, vol. 23, no. 3, pp. 1-74. https://doi.org/10.3310/hta23030","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3310/hta23030","doi":"https://doi.org/10.3310/hta23030","is_oa":true,"landing_page_url":"https://doi.org/10.3310/hta23030","pdf_url":"https://njl-admin.nihr.ac.uk/document/download/2021947","source":{"id":"https://openalex.org/S191206091","display_name":"Health Technology Assessment","issn_l":"1366-5278","issn":["1366-5278","2046-4924","2046-4932"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311817","host_organization_name":"NIHR Journals Library","host_organization_lineage":["https://openalex.org/P4310311817"],"host_organization_lineage_names":["NIHR Journals Library"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Technology Assessment","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G1481911017","display_name":null,"funder_award_id":"10/46/01","funder_id":"https://openalex.org/F4320334661","funder_display_name":"Health Technology Assessment Programme"},{"id":"https://openalex.org/G5174918796","display_name":"Naltrexone Enhanced Addiction Treatment (NEAT) for opioid dependence. A randomised controlled trial of the clinical and cost-effectiveness of implanted  extended-release naltrexone and oral naltrexone","funder_award_id":"10/46/01","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G6290355151","display_name":null,"funder_award_id":"HTA-10-46-01","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"}],"funders":[{"id":"https://openalex.org/F4320311198","display_name":"South London and Maudsley NHS Foundation Trust","ror":"https://ror.org/015803449"},{"id":"https://openalex.org/F4320312769","display_name":"Indivior","ror":"https://ror.org/05hqmp950"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320319994","display_name":"Department of Health and Social Care","ror":"https://ror.org/03sbpja79"},{"id":"https://openalex.org/F4320320285","display_name":"King's College London","ror":"https://ror.org/0220mzb33"},{"id":"https://openalex.org/F4320321067","display_name":"Public Health England","ror":"https://ror.org/00vbvha87"},{"id":"https://openalex.org/F4320334661","display_name":"Health Technology Assessment Programme","ror":"https://ror.org/0187kwz08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2911676331.pdf","grobid_xml":"https://content.openalex.org/works/W2911676331.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W1980944244","https://openalex.org/W2032973322","https://openalex.org/W2079105853","https://openalex.org/W2091022421","https://openalex.org/W2101372918","https://openalex.org/W2103464480","https://openalex.org/W2115337168","https://openalex.org/W2126283249","https://openalex.org/W2141934239","https://openalex.org/W2144969275","https://openalex.org/W2145849285","https://openalex.org/W2152243317","https://openalex.org/W2158344525","https://openalex.org/W2160313238","https://openalex.org/W3021032140","https://openalex.org/W4248856529"],"related_works":["https://openalex.org/W2807120996","https://openalex.org/W2766969415","https://openalex.org/W2132002674","https://openalex.org/W4404024399","https://openalex.org/W2003035491","https://openalex.org/W2993205759","https://openalex.org/W2145366493","https://openalex.org/W1990391721","https://openalex.org/W2327042539","https://openalex.org/W2958293187"],"abstract_inverted_index":{"BACKGROUND:":[0],"People":[1],"recovering":[2],"from":[3,513],"heroin":[4,238,425,438],"addiction":[5,101],"need":[6,495],"better":[7],"treatments":[8],"than":[9],"are":[10,482],"currently":[11],"offered.":[12],"The":[13,48,196,354,407,455],"chronic":[14],"relapsing":[15],"nature":[16],"of":[17,35,51,62,144,173,185,203,213,287,296,323,335,338,358,369,393,409,424,436,499,517],"drug":[18,206],"dependence":[19],"means":[20],"that":[21],"helping":[22],"a":[23,83,288,304,432,493,518],"patient":[24,245],"to":[25,55,226,293,318,331,352,403,414,421,477,510,529],"achieve":[26],"abstinence":[27],"is":[28,40,526],"often":[29,527],"difficult.":[30],"Naltrexone":[31,129],"blocks":[32],"the":[33,43,52,57,189,201,211,214,240,253,284,294,297,301,312,319,341,359,370,375,390,410,452,479,497,514,546],"effects":[34],"ingested":[36],"heroin;":[37],"however,":[38],"evidence":[39],"conflicting":[41],"regarding":[42],"best":[44],"delivery":[45,322],"method.":[46],"OBJECTIVES:":[47],"primary":[49,197],"purpose":[50],"trial":[53],"was":[54,82,200,418],"evaluate":[56],"clinical":[58,344,475,488,494,502],"effectiveness":[59],"and":[60,106,163,180,224,252,259,308,321,345,447,501],"cost-effectiveness":[61],"extended-release":[63],"naltrexone":[64,68,138,156,362],"versus":[65,69],"standard":[66],"oral":[67,155,372],"relapse":[70],"prevention":[71],"therapy":[72],"without":[73],"medication":[74],"for":[75,237,264,303,471,551],"opioid":[76,360],"use":[77,439],"disorder":[78],"(OUD).":[79],"DESIGN:":[80],"This":[81],"3-year,":[84],"definitive,":[85],"three-centre,":[86],"three-arm,":[87],"parallel":[88],"group,":[89],"placebo-controlled,":[90],"double-blind,":[91],"double-dummy,":[92],"randomised":[93,225],"controlled":[94],"trial.":[95,342],"SETTING:":[96],"Two":[97,230],"specialist":[98],"NHS":[99,324],"outpatient":[100],"clinics:":[102],"one":[103,107,244,248,271],"in":[104,108,387,473],"London":[105],"Birmingham.":[109],"PARTICIPANTS:":[110],"Planned":[111],"study":[112,145,174,228,298,394],"sample":[113,251],"-":[114],"300":[115],"adult":[116],"patients":[117,221,231,255,267,339],"with":[118,282,374],"OUD":[119],"who":[120],"had":[121,232,246,256,268],"completed":[122],"detoxification.":[123],"INTERVENTIONS:":[124],"One":[125],"iGen/Atral-Cipan":[126],"Extended":[127],"Release":[128],"device":[130],"(iGen/Atral-Cipan,":[131],"Castanheira":[132],"do":[133],"Ribatejo,":[134],"Portugal)":[135],"(765":[136],"mg":[137],"or":[139,153],"placebo)":[140],"at":[141,170,188,210,269,496],"day":[142,171],"0":[143,172],"week":[146,175],"1.":[147],"Three":[148],"weekly":[149],"directly":[150],"observed":[151],"active":[152],"placebo":[154],"tablets":[157],"(2":[158],"\u00d7":[159,166],"50":[160,167],"mg,":[161,168],"Monday":[162],"Wednesday;":[164],"3":[165],"Friday)":[169],"1":[176],"(for":[177,381],"4":[178],"weeks)":[179],"then":[181],"an":[182],"8-week":[183],"regimen":[184],"patient-administered":[186],"dosing":[187,191],"same":[190],"level.":[192],"MAIN":[193],"OUTCOME":[194],"MEASURE:":[195],"outcome":[198],"measure":[199],"proportion":[202],"heroin-negative":[204],"urine":[205],"screen":[207],"(UDS)":[208],"results":[209,263],"end":[212],"12-week":[215,241],"post-randomisation":[216],"time":[217,498],"point.":[218],"RESULTS:":[219],"Six":[220],"were":[222,280,440],"recruited":[223],"receive":[227],"interventions.":[229],"no":[233,383],"positive":[234,249,261],"UDS":[235,250,262,429],"samples":[236],"during":[239],"treatment":[242,326,480,531],"period,":[243],"only":[247],"remaining":[254],"two,":[257],"six":[258],"eight":[260],"heroin.":[265],"All":[266],"least":[270],"missed":[272],"clinic":[273],"visit":[274],"(range":[275],"1-14).":[276],"CONCLUSIONS:":[277],"Considerable":[278],"problems":[279],"encountered":[281],"(1)":[283],"stipulated":[285],"requirement":[286,302,516],"validated":[289],"'detoxified'":[290],"status":[291],"prior":[292],"initiation":[295],"naltrexone,":[299],"(2)":[300],"consent":[305,523],"cooling-off":[306,519],"period":[307,520],"(3)":[309],"delays":[310],"awaiting":[311],"surgical":[313],"implant":[314,379],"procedure.":[315],"Major":[316],"upheaval":[317],"organisation":[320],"community":[325],"services":[327],"across":[328],"England":[329],"led":[330],"extremely":[332],"poor":[333],"levels":[334],"actual":[336],"entry":[337],"into":[340],"Research-vital":[343],"procedural":[346],"requirements":[347],"were,":[348],"therefore,":[349],"more":[350],"challenging":[351],"implement.":[353],"potential":[355,404],"therapeutic":[356],"value":[357],"antagonist":[361],"still":[363],"needs":[364],"clear":[365],"investigation,":[366],"including":[367],"comparison":[368],"established":[371],"form":[373],"new":[376],"ultra-long-acting":[377],"depot":[378],"formulations":[380],"which":[382,474],"licensed":[384],"products":[385],"exist":[386],"Europe).":[388],"Despite":[389],"small":[391],"number":[392],"participants,":[395],"some":[396],"tentative":[397],"conclusions":[398],"can":[399],"be":[400,415,508],"reached,":[401],"relevant":[402],"future":[405,448],"work.":[406],"blinding":[408],"active/placebo":[411],"medications":[412],"appeared":[413],"good.":[416],"Self-report":[417,427],"not":[419,441],"sufficient":[420],"detect":[422],"instances":[423],"use.":[426],"plus":[428],"information":[430],"provided":[431],"fuller":[433],"picture.":[434],"Instances":[435],"lapsed":[437],"necessarily":[442],"followed":[443],"by":[444],"full":[445],"relapse,":[446],"work":[449],"should":[450,466],"consider":[451,467],"lapse-relapse":[453],"relationship.":[454],"prison":[456],"release":[457],"setting":[458],"also":[459],"warrants":[460],"special":[461],"consideration.":[462],"In":[463,504],"future,":[464],"investigators":[465],"seeking":[468],"ethics":[469],"approval":[470],"studies":[472],"procedures":[476],"accelerate":[478],"process":[481],"permitted,":[483],"even":[484],"if":[485,490],"outside":[486],"orthodox":[487],"practice,":[489],"they":[491],"address":[492],"challenge":[500],"risk.":[503],"addition,":[505],"it":[506,525],"may":[507],"appropriate":[509],"seek":[511],"exemption":[512],"ordinary":[515],"after":[521],"securing":[522],"because":[524],"essential":[528],"initiate":[530],"promptly.":[532],"TRIAL":[533],"REGISTRATION:":[534],"Current":[535],"Controlled":[536],"Trials":[537],"ISRCTN95809946.":[538],"FUNDING:":[539],";":[540],"Vol.":[541],"23,":[542],"No.":[543],"3.":[544],"See":[545],"NIHR":[547],"Journals":[548],"Library":[549],"website":[550],"further":[552],"project":[553],"information.":[554]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2019-02-21T00:00:00"}